Pham Quang X's Form 4 filing
Cadrenal Therapeutics, Inc. (CVKD) · filed Sep 6, 2023
- Accession no.
- 0001213900-23-074336
- Filed
- Sep 6, 2023
- Trade date
- Sep 5, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $36.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pham Quang XCIK 0001405290 | Director, Officer (CEO and Chairman), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2023 | Common Stock | PPurchaseAcquired | +20,000 | $0.91 | +$18,200 | 3,390,000 | Direct | |
| Sep 5, 2023 | Common Stock | PPurchaseAcquired | +20,000 | $0.90 | +$18,000 | 3,410,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.